Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/jmv.26103 http://scihub22266oqcxt.onion/10.1002/jmv.26103 32484958!7301002!32484958     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Med+Virol 2020 ; 92 (10): 2227-2231 Nephropedia Template TP {{tp|p=32484958|t=2020. Clearance and persistence of SARS-CoV-2 RNA in patients with COVID-19 |pdf=|usr=}}{{32484958}} gab.com Text Clearance and persistence of SARS-CoV-2 RNA in patients with COVID-19 JO: J Med Virol http://www.kidney.de/pget.php?&tw=1&pmid=32484958 #FOAvip Patients with coronavirus disease-2019 may be discharged based on clinical resolution of symptoms, and evidence for viral RNA clearance from the upper respiratory tract. Understanding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral clearance profile is crucial to establish a re-testing plan on discharge and ending isolation of patients. We aimed to evaluate the number of days that a patient needed to achieve undetectable levels of SARS-CoV-2 in upper respiratory tract specimens (nasopharyngeal swab and/or an oropharyngeal swab). The clearance and persistence of viral RNA was evaluated in two groups of positive patients: those who achieved two negative reverse transcription-polymerase chain reaction (RT-PCR) tests and those who kept testing positive. Patients were organized thereafter in two subgroups, mild illness patients discharged home and inpatients who had moderate to severe illness. Results from RT-PCR tests were then correlated with results from the evaluation of the immune response. The study evidenced that most patients tested positive for more than 2 weeks and that persistence of viral RNA is not necessarily associated with severe disease but may result from a weaker immune response instead. Twit Text FOAVip Clearance and persistence of SARS-CoV-2 RNA in patients with COVID-19 ????J Med Virol http://www.kidney.de/pget.php?&tw=1&pmid=32484958 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32484958 #FOAvip English Wikipedia <ref>{{Cite pmid|32484958}}</ref> Clearance and persistence of SARS-CoV-2 RNA in patients with COVID-19 #MMPMID32484958 Carmo A; Pereira-Vaz J; Mota V; Mendes A; Morais C; da Silva AC; Camilo E; Pinto CS; Cunha E; Pereira J; Coucelo M; Martinho P; Correia L; Marques G; Araujo L; Rodrigues F J Med Virol 2020[Oct]; 92 (10): 2227-2231 PMID32484958show ga Patients with coronavirus disease-2019 may be discharged based on clinical resolution of symptoms, and evidence for viral RNA clearance from the upper respiratory tract. Understanding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral clearance profile is crucial to establish a re-testing plan on discharge and ending isolation of patients. We aimed to evaluate the number of days that a patient needed to achieve undetectable levels of SARS-CoV-2 in upper respiratory tract specimens (nasopharyngeal swab and/or an oropharyngeal swab). The clearance and persistence of viral RNA was evaluated in two groups of positive patients: those who achieved two negative reverse transcription-polymerase chain reaction (RT-PCR) tests and those who kept testing positive. Patients were organized thereafter in two subgroups, mild illness patients discharged home and inpatients who had moderate to severe illness. Results from RT-PCR tests were then correlated with results from the evaluation of the immune response. The study evidenced that most patients tested positive for more than 2 weeks and that persistence of viral RNA is not necessarily associated with severe disease but may result from a weaker immune response instead. |Adult[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |COVID-19 Testing/methods[MESH] |COVID-19/*diagnosis/immunology/pathology/virology[MESH] |Child[MESH] |Convalescence[MESH] |Cross-Sectional Studies[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Nasopharynx/virology[MESH] |Oropharynx/virology[MESH] |Patient Discharge/*statistics & numerical data[MESH] |RNA, Viral/*genetics[MESH] |Retrospective Studies[MESH] |Reverse Transcriptase Polymerase Chain Reaction[MESH] |SARS-CoV-2/*genetics/immunology/pathogenicity[MESH]Clearance and persistence of SARS-CoV-2 RNA in patients with COVID-19 (epmc).pdf DeepDyve Pubget Overpricing